ENTX Entera Bio Ltd Ordinary Shares rises 442 percent on Q4 2025 EPS beat despite sharp year over year revenue decline The fundamentals driving Amneal AMRX everyone should understand Slips 20260508 RARE Ultragenyx Pharmaceutical revenue surges 20 on new drug demand but wider losses disappoint investors KYIV Kyivstar Group Ltd Common Shares rises 347 percent after Q4 2025 EPS beats analyst estimates by 152 percent Nvidia Stock at Critical Juncture Key Technical Level Could Determine Next Move Spotify and Universal Music Group Strike Landmark AI Licensing Deal for UserGenerated Remixes Bond Yields Likely to Remain Elevated Amid Geopolitical Uncertainty Market Signals Suggest Stork vs Drone Natures Edge Inspires NextGen UAV Design Google Pixel Launch Google Assistants AI Capabilities Intensify Privacy Debate Bitcoin Risks Further Decline Despite Rating Upgrade Analyst Perspective Wholesale Inflation Surges 6 Annually in April Marking Largest Jump Since 2022